Sector ratings Merck & Co., Inc.

Stocks

Market Closed - NYSE Other stock markets 06:03:54 18/06/26 am AEST			After hours 10:00:00 am
115.44 ^USD	+0.23%		121.40	+5.16%

16/06	Merck Signs Drug Discovery, Licensing Deal With Protillion Biosciences	MT
16/06	Moderna announces executive changes ahead of potential launches	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
MERCK & CO., INC.	284B		A
MERCK KGAA	66.62B		AAA
HALOZYME THERAPEUTICS, INC.	8.26B		BBB
KYOWA KIRIN CO., LTD.	7.84B		AA
SK BIOPHARMACEUTICALS CO., LTD.	4.6B		AAA
YUHAN CORPORATION	3.87B		AA
BETTA PHARMACEUTICALS CO., LTD.	3.15B		-			-
SUPERNUS PHARMACEUTICALS, INC.	2.53B	-	BB	-		-
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	1.95B	-	-	-	-	-	-	-
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	1.68B	-	-	-		-	-	-
VELOXIS PHARMACEUTICALS A/S	1.64B	-	-	-	-	-	-	-
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.	1.64B	-	-	-		-	-
MEZZION PHARMA CO.,LTD.	1.29B	-	BBB	-	-	-	-	-
SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.	1.22B	-	-	-	-	-	-	-
KISSEI PHARMACEUTICAL CO., LTD.	1.03B		BBB
DBV TECHNOLOGIES	1.01B	-	-	-		-
FRONTIER BIOTECHNOLOGIES INC.	997M	-	-	-	-	-	-	-
OSCOTEC INC.	985M		CCC				-
ETON PHARMACEUTICALS, INC.	886M	-	-	-		-
YOUCARE PHARMACEUTICAL GROUP CO., LTD.	871M	-	-	-		-	-	-
Average	19.83B		A
Weighted average by Cap.			A